Related Experiment Videos
Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights
Andrea Fandella1, Vincenzo Scattoni2, Andrea Galosi3
1Department of Urology, Giovanni XXIII Clinic, Monastier di Treviso, Treviso, Italy.
Anticancer Research
|February 10, 2017
Summary
Updated Italian guidelines recommend initial prostate biopsies for elevated PSA, abnormal rectal exams, or suspicious MRI findings (PIRADS ≥4). Multiparametric MRI is advised for prior negative biopsies, with at least 12 cores plus targeted biopsies recommended.
Area of Science:
- Urology
- Pathology
- Radiology
Background:
- Prostate biopsies are crucial for diagnosing prostate cancer.
- Guidelines require regular updates based on emerging evidence.
Purpose of the Study:
- To summarize updated Italian Prostate Biopsies Group guidelines.
- Incorporate recent literature evidence (2012-2015) into recommendations.
Main Methods:
- Systematic review of English-language literature (2012-2015).
- Expert panel (14 urology, pathology, radiology specialists).
- Evidence grading using the GRADE framework.
Main Results:
- Initial biopsy recommended for PSA >10 ng/ml, abnormal DRE, or PIRADS ≥4 on mpMRI.
- mpMRI strongly recommended for patients with prior negative biopsies.
- Minimum 12 cores plus targeted biopsies; saturation biopsies are optional.
- Gleason grade groups recommended alongside Gleason score.
Conclusions:
- Updated guidelines aid physician and patient decision-making for prostate biopsies.
- Emphasize the role of mpMRI in guiding biopsy decisions.